Navigation Links
Drug Repurposing, Rescue, and Repositioning: A groundbreaking new journal from Mary Ann Liebert, Inc.
Date:12/11/2013

New Rochelle, NY, December 11, 2013Mary Ann Liebert, Inc., publishers is pleased to announce Drug Repurposing, Rescue, and Repositioning, a dynamic new peer-reviewed journal that will present techniques and tools for finding new uses for approved drugsparticularly for disorders where no animal model, physiologic abnormality, biochemical pathway, or molecular target has been identified. The Journal will be published online with open access options and in print, and is currently under the leadership of Managing Editor Bill Ferguson, PhD.

Repurposing allows human investigation early in the drug discovery process, speeding up the development of important therapeutics. Repurposing can be an important tool in dissecting complex disorders, discovering molecular targets, and unraveling disease processes leading to therapeutic compounds for drug discovery and development. Drug "rescue" refers to research using small molecules and biologics that previously were used in studies but not further developed and submitted for Food and Drug Administration (FDA) approval. Drug repositioning is a scientifically logical process for finding new uses for drugs in well-defined and selected patient populations. These initiatives have attracted the attention of regulators around the world; the National Institutes of Health in the United States has launched its National Center for Advancing Translational Medicine (NCATS), with the goal of promoting drug repurposing by industry. There are also several similar European and Asian initiatives already well underway.

Drug Repurposing, Rescue, and Repositioning will include original papers, application-oriented technology reviews, and reports in methodology and technology application. Timely and authoritative articles will cover topics such as: assay design, target development, high-throughput technologies, and chemistry; lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis; approaches to assays configured for gene families, inherited, and infectious diseases; assays and strategies for adapting model organisms to drug discovery; the use of stem cells as models of disease; translation of phenotypic outputs to target identification; and exploration and mechanistic studies of the technical basis for assay and screening artifacts.


'/>"/>

Contact: Bill Ferguson
bferguson@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

Related biology news :

1. Lawson recieves Grand Challenges Explorations grant for groundbreaking research
2. Groundbreaking discovery of the cellular origin of cervical cancer
3. Groundbreaking discovery of mechanism that controls obesity, atherosclerosis
4. UCLA Receives $46 Thousand Check for Groundbreaking Research on Debilitating Pregnancy Disease
5. Soft Robotics: A groundbreaking new journal on engineered soft devices that Interact with Living Systems
6. A*STAR scientists groundbreaking discovery of nucleus structure crucial to understanding diseases
7. MSU launches groundbreaking drug trial in Africa
8. DNA SPECTRUM LAUNCHES GROUNDBREAKING DNA STORAGE PRODUCT
9. Canadian researchers lead groundbreaking discovery in deadly childhood cancer
10. Tips from the journal mBio
11. Canadian Journal of Cardiology publishes new atrial fibrillation guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... subsidiary of Infosys (NYSE: INFY ), and Samsung ... global partnership that will provide end customers with a ... and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... for financial services, but it also plays a fundamental part ...
(Date:4/15/2016)... , April 15, 2016  A new partnership ... more accurate underwriting decisions in a fraction of ... competitively priced and high-value life insurance policies to ... With Force Diagnostics, rapid testing (A1C, ... data readings (blood pressure, weight, pulse, BMI, and ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
Breaking Biology News(10 mins):
(Date:5/23/2016)... ... May 23, 2016 , ... Foresight Institute , ... the winners for the 2015 Foresight Institute Feynman Prizes. , These prestigious ... categories, one for experiment and the other for theory in nanotechnology. Prof. Markus ...
(Date:5/20/2016)... ... , ... Kablooe Design, a leading provider of product design and development services ... the business. “We have worked hard to build long-term relationships,” says President and CEO, ... honor of serving their product design and development needs through the years.” , Kablooe ...
(Date:5/19/2016)... (PRWEB) , ... May 19, 2016 , ... Anton Paar ... 30,000 square foot office building is complete. The new structure adds a third office ... Anton Paar USA purchased 2.4 acres of land, along with office space ...
(Date:5/19/2016)... , ... May 19, 2016 , ... ... organization (CRO) has welcomed Abu Siddiqui as Director, Large Molecule & Biomarker Bioanalysis. ... biologics, vaccine and translational biomarker discovery studies for preclinical and clinical safety programs. ...
Breaking Biology Technology: